243 filings
Page 4 of 13
8-K
ht1t48qslmy75lc7
4 Aug 21
CytoSorbents Reports Second Quarter 2021 Financial and Second Quarter 2021 Financial Highlights
12:00am
8-K
tmqekx52yksjxxoh6
27 Jul 21
Termination of a Material Definitive Agreement
5:04pm
8-K
owe5vb1srz 4p
6 Jul 21
Other Events
4:10pm
8-K
5mriow9 co99
2 Jun 21
Submission of Matters to a Vote of Security Holders
12:00am
8-K
js2ibi
5 May 21
CytoSorbents Reports First Quarter 2021 Financial and Operational Results
6:03am
8-K
x686t
20 Apr 21
U.S. FDA Approves CytoSorbents to Initiate U.S. STAR-T Trial For Ticagrelor Removal During Cardiothoracic Surgery
4:30pm
8-K
46n3eb
15 Apr 21
Departure of Directors or Certain Officers
12:00am
8-K
sp3x3
8 Apr 21
Amendments to Articles of Incorporation or Bylaws
4:50pm
8-K
eqipxon1577
31 Mar 21
CytoSorbents Announces Lease of New Global Headquarters in Princeton, New Jersey
4:21pm
8-K
a9jibt xvmzt
17 Mar 21
CytoSorbents Announces Filing of an Investigational Device Exemption (IDE) for U.S. Trial on Ticagrelor Removal During Cardiothoracic Surgery
4:30pm
8-K
1r7so5pl98b6b fx
9 Mar 21
CytoSorbents Announces 2020 Financial and Operational Results
4:30pm
8-K
pqg2he71
18 Feb 21
Other Events
4:30pm
8-K
gtb7v b3z23p
12 Jan 21
CytoSorbents Reports Preliminary Fourth Quarter and Full Year 2020 Revenue
4:30pm
8-K
ymtxiq1s cyytjxdwqmt
10 Dec 20
Entry into a Material Definitive Agreement
4:30pm
8-K
cvowk 3u2t
5 Nov 20
CytoSorbents Reports Record Third Quarter 2020 Financial Results
12:00am
8-K
nub58jd g1fhf0xe7
4 Aug 20
CytoSorbents Reports Record Second Quarter 2020 Financial Results
5:01pm
8-K
izyoxz55g2tr335knbm
24 Jul 20
Other Events
4:08pm
8-K
5z2juv4epevdoxmg
22 Jul 20
CytoSorbents Corporation Announces Pricing of $50 Million Public Offering of Common Stock
5:26pm
8-K
h9km2hoi 7zu
21 Jul 20
Other Events
9:30pm
8-K
qf5v0jusjf2r1f 3bhh
20 Jul 20
CytoSorbents Provides Preliminary Q2 2020 Financial Results and Corporate Update
4:49pm